Effect of Clupeonella grimmi (anchovy/kilka) fish oil on dysmenorrhoea;Effet de l'huile de Clupeonella grimmi (anchois/kilka) sur la dysménorrhée

Eastern Mediterranean Health Journal

Volumn 16, Issue 4, 2010, Pages 407-413

  Moghadamnia, A A ^a   Mirhosseini, N ^b   Hajiabadi, M ^a   Omranirad, A ^a   Omidvar, Sh ^a  

^a BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Obstetric and Gynaecology Clinic   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CLUPEONELLA GRIMMI FISH OIL; DOCOSAHEXAENOIC ACID; FISH OIL; IBUPROFEN; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; PLACEBO; RETINOL; UNCLASSIFIED DRUG; VITAMIN D;

ABDOMINAL PAIN; ADULT; ANCHOVY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CLUPEONELLA GRIMMI; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DYSMENORRHEA; FEMALE; FOLLOW UP; HUMAN; LOW BACK PAIN; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SINGLE DRUG DOSE; SYMPTOM; TREATMENT DURATION; VISUAL ANALOG SCALE; CHEMISTRY; CHI SQUARE DISTRIBUTION; EMULSION; HOSPITALIZATION; IRAN; NONPARAMETRIC TEST; PAIN ASSESSMENT; PATIENT SATISFACTION; PSYCHOLOGICAL ASPECT; TREATMENT OUTCOME;

CHEMISTRY, PHARMACEUTICAL; CHI-SQUARE DISTRIBUTION; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; DYSMENORRHEA; EICOSAPENTAENOIC ACID; EMULSIONS; FEMALE; HUMANS; IRAN; PAIN MEASUREMENT; PATIENT SATISFACTION; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77953735849     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: 10.26719/2010.16.4.408     Document Type: Article

References (24)

1. Dawood MY. Nonsteroidal antiinflammatory drugs and reproduction. American journal of obstetrics & gynecology, 1993, 169(5):1255-1265.
2. Deligeoroglou E. Dysmenorrhea. Annals of the New York Academy of Science, 2000, 900:237-244.
3. Klein JR, Litt IF. Epidemiology of adolescent dysmenorrhea. Pediatrics, 1981, 68(5):661-664.
4. O'Connell K, Davis AR, Westhoff C. Self-treatment patterns among adolescent girls with dysmenorrhea. Journal of pediatric and adolescent gynecology, 2006, 19(4):285-289.
5. Alvin PE, Litt IF, Current status of the etiology and management of dysmenorrhea in adolescence. Pediatrics, 1982, 70(4):516-525.
6. Bieglmayer C et al. Concentrations of various arachidonic acid metabolites in menstrual fluid are associated with menstrual pain and are influenced by hormonal contraceptives. Gynecological endocrinology, 1995, 9(4):307-312.
7. Owen PR. Prostaglandin synthetase inhibitors in the treatment of primary dysmenorrhea. Outcome trials reviewed. American journal of obstetrics & gynecology, 1984, 148(1):96-103.
8. Mehlisch DR, Ardia A, Pallotta T. Analgesia with ibuprofen arginate versus conventional ibuprofen for patients with dysmenorrhea: A crossover trial. Current therapeutic research, 2003, 64(6):327-337.
9. Hansen HS, Olsen SF. Dietary (n-3)-fatty acids, prostaglandins, and prolonged gestation in humans. Progress in clinical and biological research, 1988, 282:305-317.
10. Deutch B. Menstrual pain in Danish women correlated with low n-3 polyunsaturated fatty acid intake. European journal of clinical nutrition, 1995, 49(7):508-516.
11. Lee TH et al. Effects of exogenous arachidonic, eicosapen-taenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. Journal of clinical investigation, 1984, 74(6):1922-1933.
12. Jafroodi H, Khatami M. [Gas chromatography identification of fatty acids in Caspian Sea Anchovy fish oil]. North Shilat, 1995, 9:36-44 (in Farsi).
13. Harel Z et al. Supplementation with omega-3 polyunsaturated fatty acids in the management of dysmenorrhea in adolescents. American journal of obstetrics & gynecology, 1996, 174(4):1335-1338.
14. Schmidt EB et al. n-3 polyunsaturated fatty acid supplementation (Pikasol) in men with moderate and severe hypertrig-lyceridaemia: a dose-response study. Annals of nutrition & metabolism, 1992, 36,(5-6);283-287.
15. Juang CM et al. Impact of pregnancy on primary dysmenorrhea. International journal of gynaecology and obstetrics, 2006, 92(3):221-227.
16. Vercellini P et al. Endometriosis and pelvic pain: relation to disease stage and localization. Fertility and sterility, 1996, 65(2):299-304.
17. Kennedy S. Primary dysmenorrhoea. Lancet, 1997, 349(9059):1116.
18. Benedetto C. Eicosanoids in primary dysmenorrhea, endome-triosis and menstrual migraine. Gynecological endocrinology, 1989, 3(1):71-94.
19. Balbi C et al. Influence of menstrual factors and dietary habits on menstrual pain in adolescence age. European journal of obstetrics & gynecology and reproductive biology, 2000, 91(2):143-148.
20. Wu MH et al. Endometriosis: disease pathophysiology and the role of prostaglandins. Expert reviews in molecular medicine, 2007. 9(2):1-20.
21. Fox PL, DiCorleto PE. Fish oils inhibit endothelial cell production of platelet-derived growth factor-like protein. Science, 1988, 241(4864):453-456.
22. Penland JG, Johnson PE. Dietary calcium and manganese effects on menstrual cycle symptoms. American journal of obstetrics & gynecology, 1993, 168(5):1417-1423.
23. Vapaatalo H. Tolfenamic acid and migraine-aspects on prostaglandins and leukotrienes. Pharmacology & toxicology 1994, 75(Suppl. 2):76-80.
24. Daniels SE, Torri S, Desjardins PJ. Valdecoxib for treatment of primary dysmenorrhea. Journal of general internal medicine, 2004, 20:62-7.